Table 1.

The association between DPYSL2 expression and prognosis in LUAD based on Kaplan–Meier plotter analysis

	Overall survival (n = 719)				Progression-free survival (n = 641)
	N	HR (95% CI)	p value		N	HR (95% CI)	p value
Gender
Female	317	0.29 (0.19–0.45)	2.3e−09		235	1.99 (1.25–3.17)	0.0032
Male	344	0.49 (0.34–0.68)	2.6e−05		226	2.96 (1.86–4.7)	1.5e−06
Stage
1	370	0.34 (0.22–0.52)	2.1e−07		283	2.75 (1.65–4.61)	5.8e−05
2	136	0.43 (0.26–0.72)	8e−04		103	1.38 (0.8–2.4)	0.25
3	24	0.72 (0.25–2.07)	0.54		10	–	–
4	4	–	–		0	–	–
T stage
1	123	0.67 (0.36–1.24)	0.2		47	7.47 (0.89–62.42)	0.029
2	105	0.77 (0.44–1.33)	0.34		93	1.59 (0.84–3.01)	0.15
3	4	–	–		2	–	–
4	0	–	–		0	–	–
N stage
0	184	1.87 (1.14–3.05)	0.011		102	1.49 (0.68–3.25)	0.31
1	44	1.18 (0.54–2.57)	0.68		38	3.16 (1.23–8.13)	0.012
2	3	–	–		2	–	–
M stage
0	231	1.56 (1.04–2.34)	0.028		142	2.17 (1.19–3.93)	0.0093
1	1	–	–		0	–	–
Smoke
Ever	246	2.03 (1.25–3.28)	0.0033		243	2.29(1.46–3.6)	0.00021
Never	143	3.42 (1.35–8.62)	0.0057		143	3.1 (1.58–6.07)	5e−04

HR hazard ratio, CI confidence interval. Values in bold indicate p < 0.05